Why is Beta Drugs Ltd falling/rising?

As of 15-Jul, Beta Drugs Ltd is experiencing a decline in its stock price, currently at 1,730.00, which reflects a decrease of 9.95 or 0.57%. The stock has underperformed its sector by 1.82% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has seen a return of -2.46%, and over the past month, it has declined by 4.42%. Despite a strong performance over the longer term, with a 50.07% increase over the past year and a staggering 2703.78% rise over five years, the recent trends indicate a downturn. The delivery volume has increased significantly, rising by 100% against the 5-day average, suggesting a potential shift in investor interest, although the absence of specific positive or negative factors makes it difficult to ascertain the reasons behind the current price movement.
In the broader market context, Beta Drugs Ltd's recent performance contrasts with the benchmark Sensex, which has shown a decline of only 1.28% over the past week and an increase of 1.93% over the past month. This indicates that while the stock is facing challenges, the overall market is performing relatively better in the short term. The year-to-date performance also highlights a significant underperformance of Beta Drugs Ltd compared to the Sensex, with a decline of 9.36% against a rise of 6.56% for the benchmark. This disparity may contribute to investor sentiment and the stock's current downward trajectory.